Christie is a PhD student in the Immunology program at Stanford. She received her bachelor’s in Computer Science and Genetics from Rutgers University in 2017. During this time, she worked in the lab of Dr. Lei Yu, studying the molecular pathway for neuropathic pain therapeutic targets. After graduation, she joined Dr. Miriam Merad’s lab at the Icahn School of Medicine at Mount Sinai, where she optimized multi-dimensional assays for use in immunotherapy clinical trials. Christie is interested in implementing cutting-edge technologies to better understand immunological changes in disease.

Back to front

Andy is a first year PhD student in the Bioengineering department at Stanford. He received a BS in Physics and an MD from National Cheng Kung University in Taiwan, where he studied nanoparticle-based platforms for the diagnostics and therapeutics. Last quarter, Andy worked on computational modeling of cancer early detection and evolution under Dr. Johannes Reiter at Stanford’s Radiology Dept. Andy is interested in deciphering and engineering immune responses for clinical translation with computational analysis and genome editing tools. 

Back to front

Yu-Chia is a rotating graduate student in the Genetics program. Yu-Chia graduated from Penn where she studied Biology and Finance in the Vagelos Life Sciences and Management Dual-Degree Program. As an undergraduate student, she worked in Jon Epstein’s lab where she studied epigenetic mechanisms that drive nuclear architecture. Before graduate school, she was an analyst in the biotech group at Centerview Partners. Moving forward, Yu-Chia aims to combine her epigenetics background with synthetic biology and screening to build chimeric epigenetic factors.

Back to front

Peter is PhD student in the Cancer Biology program. He received his bachelor’s degree from Princeton in 2017 and worked as a computational biologist at the Broad Institute following graduation. As a jointed advised student in the Satpathy and Bassik labs, Peter is interested in using single cell technologies and functional genomics to dissect cell communication circuits in the tumor microenvironment.

Back to front

Alex is a Life Science Research Professional in the Satpathy Lab at the Stanford University School of Medicine. Alex graduated from Penn with coursework in health policy and chemistry in 2024.  As an undergraduate student, he worked in Dr. Brad Wood’s lab at the National Institutes of Health (NIH) Clinical Center while a 2023 Amgen Scholar, researching novel drug delivery methods for hepatocellular carcinoma-targeting immunotherapeutic agents. As an LSRP with the Satpathy and Mackall groups, Alex is interested in learning how natural immunosuppressive response can be modulated in vivo to improve the success of LBCL-directed CAR T therapies.

Back to front

Sager earned his PhD in 2022 from Harvard University, working in Pardis Sabeti’s lab at the Broad Institute. His doctoral research focused on developing machine learning approaches for designing synthetic DNA regulatory elements, analyzing CRISPR screen data, and identifying signatures of adaptive evolution in human populations. Prior to his PhD, he worked with Gary Silverman at the University of Pittsburgh, where he used model organisms to advance drug discovery efforts, and with Brian Gregory at the University of Pennsylvania, studying RNA-protein interactions in plant development. Currently, as a postdoc in the Satpathy lab, Sager is developing novel artificial intelligence tools to accelerate therapeutic discovery and development.

Back to front

Austin is a rotating graduate student in the Genetics program at Stanford. He studied Computer Science as an undergraduate at Santa Clara University. Before graduate school, he worked in software at 10x Genomics and then in Dr. Rahul Satija’s lab developing tools for single cell and spatial genomics. Going forward, he hopes to apply multiomic methods with different kinds of perturbations to build better cell therapies and predictably manipulate cell function.

Back to front

Kamir received his PhD in Biomedical Sciences from the University of California San Francisco in 2020. His PhD work in the Spitzer lab fused experimental and computational immunology to decipher the dynamic regulation of CD8 T cell priming in cancer and infection. As a CRI Irvington Postdoctoral Fellow in the Satpathy lab, Kamir aims to develop and apply lineage recording tools combined with multimodal single cell omics to decode the regulatory logic guiding the differentiation of cytotoxic CD4 T cells. 

Back to front

Sidney is a Research Associate I at the Gladstone Institutes. She received her bachelor’s degree in Chemistry with a Biochemistry concentration and Health Studies minor from Haverford College. During her undergraduate education, she completed a senior thesis in biophysics in the lab of Dr. Casey Londergan, using vibrational spectroscopy to study protein conformational dynamics. In the Satpathy lab, Sidney is interested in creating new gene delivery technologies and learning more about cancer immunotherapies. 

Back to front

Nicole is an undergraduate research assistant pursuing a bioengineering degree at Stanford University. She has previously worked on microarray patches for vaccine delivery in the DeSimone Lab. In the Satpathy Lab, she is exploring pooled T cell screening methods for cancer immunotherapy. Nicole is especially interested in medicine and advancing cell-based therapies for clinical applications.

Back to front

Siva is a Fellow in Pediatric Rheumatology. He is a board-certified pediatrician and completed combined MD-PhD training at the University of Washington and Fred Hutchinson Cancer Center in Seattle. His thesis research focused on developing genomic technologies for chromatin profiling and centromere biology. Siva’s current clinical and research interests include the genetics of immune dysregulation. In the Satpathy lab, he aims to develop and apply new methods to better understand clonal dynamics in autoimmune disease.

Back to front

Courtney is a Life Science Research Professional I in the Satpathy Lab. She graduated from the University of Michigan with a Bachelor’s of Science in Biopsychology, Cognition and Neuroscience. At U of M, she explored what underlies the stress-vulnerability to negative affect in psychosis spectrum disorders using EEG. In the Satpathy Lab, she is excited to use gene editing and pooled screening in T cells to develop new cancer immunotherapies.

Back to front

Madeline graduated from UC Berkeley with her B.A. in Integrative Human Biology. She has been working in laboratories since high school across UCSF, UC Berkeley, and UC Davis campuses. She has always had a profound fascination with genome engineering and has been able to work most recently in Alex Marson’s laboratory at Gladstone Institutes working on large scale CRISPR screens. Prior to the Marson Lab Madeline worked at the Chan Zuckerberg Biohub as a Supervisor. 

Back to front

Vincent is a PhD student in the Genetics program. He received his bachelor’s in Computer Science and Statistics from Columbia University in 2019. Initially working as an undergraduate researcher and later as a full-time research associate in the Dana Pe’er Lab at MSKCC, he applied single-cell genomics and lineage tracing technologies to study mouse embryonic development, tumor drug resistance, and human cancer metastasis. At Stanford, Vincent hopes to develop and apply single-cell multiomic technologies to gain a better understanding of the immune system in both healthy and disease states.

Back to front

My name is Johnathan and I am a recent graduate from the Rochester Institute of Technology. During my time there I investigated if it’s possible to use a commercially available kit to profile the intestinal microbiome and study the intestinal microbiome of patients with Parkinson’s Disease for microbes that affect the Vagus nerve in relation to the brain. The results will inform us of microbiome differences and allow the comparison between normal and diseased populations. Understanding the effects of the microbiome on the brain, would open new doorways within the world of psychiatric medicine and hopefully lead to new treatments. 

Pivoting from microbiome work, I am currently exploring gene editing using CRISPR Cas-9 technology and discovering different approaches to editing T-Cells to be more effective in fighting against cancers. I find myself learning new techniques and instruments and overall have an increasing interest in gene therapy work!

Back to front

Saba is a Life Science Research Professional in the Satpathy Lab at the Stanford University School of Medicine. Saba graduated from UC Berkeley with a BA emphasizing in immunology and molecular medicine in 2023. Throughout undergrad, she worked in Dr. James Bayrer’s lab at UCSF researching the function of human LRH-1 in bile acid transport in the gut intestinal epithelium and its correlation to fatty liver disease. In the Satpathy Lab, Saba is interested in how immunology can be applied in cancer therapies through cancer immunotherapy.

Back to front

Ali is a Life Science Research Professional I supporting immunology research at the Stanford Blood Center.
She graduated from Cornell University with a Bachelor’s of Science in Biological Sciences. At Cornell, she investigated the effects of the GPX-1 enzyme on cellular concentrations of selenium and zinc in liver and pancreas tissue utilizing TEM imaging.
At Stanford, she works as a part of a multidisciplinary group, designing and constructing DNA sequences for cellular engineering experiments, isolating and culturing primary human immune cells, and performing functional analysis of engineered cells via flow cytometry and cancer co-culture assays. She is excited to follow science and see where it takes her!

Back to front

Chris received his PhD from University of California San Francisco in 2021. As a graduate student in the Gartner lab, Chris developed computational and molecular tools for single-cell transcriptomics and epigenomics, including DoubletFinder, MULTI-seq, and MULTI-ATAC-seq. He additionally used these methods to perform high-throughput immunomodulatory drug screens at single-cell resolution. As a postdoctoral fellow in the Satpathy lab, Chris will apply his background in single-cell genomics, immunology, and computational biology to fundamental questions in the cancer immunology field, including how tumors reprogram the immune system during metastasis.

Back to front

Lauren is a Center Administrator in the Department of Pathology, supporting three Centers funded by NHGRI and NIAID. Lauren previously served as the Assistant Director of the Translational Research Institute on Pain in Later Life at Weill Cornell Medicine, and most recently as the Research Program Manager for the Patient Centered Injury Prevention Lab at University of Colorado School of Medicine. 

Back to front

Becca graduated from UC Santa Barbara in 2019 with a degree in Cell and Developmental Biology.  After graduating, she worked in industry developing and optimizing personalized T Cell therapies against solid tumors. At Stanford she is working on gene delivery methods and characterizing regulatory elements in different cell types.

Back to front

Max is a PhD student in the Satpathy Lab. He is a first-year graduate student in the genetics program. He graduated from Harvard University with a Bachelor’s Degree in Chemical and Physical Biology in 2019. During his undergraduate studies, he worked in Dr. Vijay Kuchroo’s lab and Dr. David Liu’s lab.

Back to front

Laura earned her doctoral degree from University of Regensburg in the lab of Matthias Edinger & Petra Hoffmann, where she conducted experimental thesis work on engineering regulatory T cells as an adoptive cellular therapy for GvHD. As a pediatric resident at the University Hospital Frankfurt her clinical work in the department of Stem Cell Transplantation & Immunology of Peter Bader focused on adoptive cellular therapies including CAR-T cell therapy. In the lab of Eva Rettinger she has investigated cytokine-induced killer cells as effector cells for CAR engineering in solid tumors. As a post-doc in the Satpathy lab she will continue her research in pediatric immunotherapy, exploring the diversity of immune effector cells and their trajectories to enhance the effectiveness of targeted immunotherapies in solid tumors.

Back to front

Richard is a rising 2nd year medical student at the Morehouse School of Medicine in Atlanta GA. He received a BS in Chemistry from Emory University, where he worked as an undergraduate and research specialist studying protein-protein interactions involved in Alzheimer’s disease in hopes of developing new potential therapeutics. He is here for the summer as a visiting medical student doing research with a focus in studying tumor metastasis using both wet-lab and computational techniques. Richard is interested in translating discoveries made in the lab to the clinical side where he hopes to go into academic medicine.

Back to front

Back to front

Colin is a PhD student in the Immunology Program. He graduated from Tufts University in 2019 with a degree in Biology. While at Tufts, he studied the functional role of tandem repeat regions in proteins. Before starting at Stanford, Colin worked at SQZ Biotech developing a cell therapy to induce antigen-specific tolerance for the treatment of autoimmune diseases. In the Satpathy lab, he is interested in addressing basic hypotheses in T cell biology by combining fundamental immunological systems with high-throughput genomic techniques. 

Back to front

Katherine completed her PhD in 2011 at the University of Florida studying early fate specification in mouse embryonic stem cells in the laboratory of Naohiro Terada, MD,PhD. Upon graduation, she co-founded the Center for Cellular Reprogramming at the University to reprogram somatic cells to iPSCs and subsequently differentiate iPSCs for collaborative research studies. To pursue a long-standing interest in iPSC-derived immune cell therapy, she worked in Industry as an R&D scientist at Fate Therapeutics and Century Therapeutics to differentiate and characterize iPSC-derived T cells. From 2023-2024 she took a career break to pursue long-distance backpacking and explore the western US. Going forward as a staff scientist in the Roth and Satpathy labs, Katherine is excited to apply scalable genome perturbations to iPSCs and iPSC-derived lineages to explore novel cell states.

Back to front

Ansu Satpathy, M.D., Ph.D., is a physician-scientist and Associate Professor of Pathology and Immunology at Stanford University. He is the founding director of the Stanford Center for Immunotherapy Design, co-director of the Parker Institute for Cancer Immunotherapy, and co-leader of the Stanford Cancer Institute Immunotherapy Program. Ansu’s research combines expertise in immunology, high-throughput genomics, and computation to discover principles of the immune system in health and disease and to translate these discoveries into novel clinical therapeutics. Ansu holds a BS in molecular biology and BA in philosophy from the University of Illinois, an MD and PhD in immunology from Washington University in St.Louis, and completed his clinical residency and postdoctoral training in genetics at Stanford University.

Back to front

Quanming Shi is a joint Research Associate in Satpathy lab and Chang lab. He received Bachelor’s degree in Chemical Engineering from Tsinghua university, and Ph.D in Chemical and Biomolecular Engineering at U of Illinois at Urbana Champaign, where he studied single molecular binding force measurement and cellular mechanotranduction in developmental and cancer context. He worked on single molecule imaging, CRISPR editing and tagging, and coupling with genomics to study protein and DNA binding during Postdoctoral training at UC Berkeley and Stanford. Currently he primarily focuses on single cell multi-omics and CRISPR screening.

Back to front

Back to front

Bob received his PhD from Harvard University where he worked with Evan Macosko and Fei Chen developing spatial transcriptomic technologies enabling organ level reconstruction of gene expression with cellular resolution. Prior to his PhD he worked on protein sequencing technologies at WUSTL, and evolutionary genomics during his undergraduate at University of Connecticut. In the Satpathy lab he will be working on new gene delivery technologies to convert the rich information generated from single cell data to highly specific delivery modalities. 

Back to front

Oliver is a graduate student in the Immunology program. As an undergraduate at Tufts, he studied DNA repair of trinucleotide repeat tracts using Baker’s yeast as a model. Prior to graduate school, he spent several years at ArsenalBio developing cell therapies. Oliver hopes to leverage functional genomics and gene editing tools to further understand and manipulate T cell phenotypes. Outside of lab, you may find him biking in the Bay Area or skiing in Tahoe.

Back to front

Nicole is an undergraduate at Stanford University pursuing a B.S in Chemistry. As a research assistant during the summer and part-time during the year, she optimized the design of clonal barcodes and an iterative re-opening plasmid. Her work in the lab consists of using restriction enzymes to insert new genes and use those templates to genetically modify T cells. She is interested in seeing which modifications, as well as which cell clones, outperform other engineered T cells in pooled screen cancer assays. Along with her passion for chemistry, she hopes to continue improving sequencing technology for small-scale experiments.

Back to front

Vivien pursued her PhD training in the lab of Emile Voest at the Netherlands Cancer Institute in Amsterdam, where she dissected personalized tumor immune cell interactions using patient derived tumor organoids. Next to understanding autologous T cell responses, her PhD work focused on the anti-tumor role of immune cells outside of the adaptive immune system, such as gamma delta T cells and NK cells. As a postdoctoral fellow in the Satpathy lab, Vivien will pursue her fascination with the complex interplay of tumor and immune cells and apply her cancer biology background from her bachelor and master studies in biochemistry to study cellular responses to cancer immunotherapy, specifically identifying immune cell crosstalk relevant for effective tumor recognition and elimination.

Back to front

Fangyi is a Life Science Research Professional 1 in the lab. Prior to joining the Satpathy Lab, she worked in Dr. Yanfen Liu’s lab at ShanghaiTech University during the summer of 2021 to study ubiquitin-proteasome and autophagy regulation with an emphasis on ubiquitin ligases. In the Satpathy Lab, Fangyi is interested in using cancer immunotherapy and how immunology can be applied in cancer therapy.

Back to front

Lujing is a Life Science Research Professional in the Satpathy lab at the Stanford University School of Medicine. Lujing graduated from the University of California, San Diego with a Bachelor’s Degree in Human biology and a Master’s Degree in Biology. At UCSD, he worked on the role of RNA methylation in cancer progression and cancer immunotherapy, as well as developing CAR-NK cell therapies against solid tumors. At Stanford, he is interested in using pooled genetic screens to explore novel gene candidates that improves CAR-T cell efficacy against cancer.

Back to front

Pat is a graduate student in the Stanford Immunology program. He graduated from Penn State with a bachelor’s in Chemistry in 2016. After graduation, he studied the mechanisms of immune checkpoint blockade therapy in melanoma patients in the lab of Dr. John Wherry. He then worked on transcriptional control of CAR T cells at ArsenalBio. Pat currently focuses on understanding the molecular and signaling events that regulate T cell memory fate decisions. Outside of the lab he enjoys searching the California coast for rocks to climb.

Back to front

Winnie is a Life science research professional 1 (LSRP1) in Satpathy lab in the Department of Pathology. She obtained her Bachelor Degree from UC Berkeley in 2016. Before joining the Satpathy lab, she worked as a LSRP1 in Mark M. Davis lab in the Department of Microbiology and Immunology.

Back to front

Jennifer received her Ph.D. degree from Washington University in St. Louis in 2025. While at WashU, she worked in the Stewart Lab to study breast cancer tumor microenvironment. Her work emphasized understanding how tumor stroma, specifically senescent cancer-associated fibroblasts, modulate tumor immunity and promote breast cancer tumorigenesis. Prior to her graduate school training, Jennifer obtained her B.A. degree from Colby College, where she worked in the Millard Lab and focused on determining how carcinogen-DNA adducts impact human polymerase beta’s function. As a postdoctoral fellow in the Satpathy Lab, Jennifer is interested in applying single-cell and spatial genomics to study how tumors reprogram stromal compartments to escape from immunosurveillance and establish metastasis.

Back to front

Yajie is a Life science research professional 1 (LSRP1) in Satpathy lab in the Department of Pathology. Yajie obtained her Bachelor Degree of Clinical Medicine, evaluated as MD, from Weifang Medical University China in 2013, and received the Master degree in Oncology in 2017. From 2015 to 2019, she worked on Gynecology Oncology in Dr. Bae-Jump lab as a Visiting Scholar & Research Assistant at the University of North Carolina at Chapel Hill. She continued to explore her study on clinical research and received the Master Degree in Biomedical and Translational Science from University of California, Irvine, in 2020. Before joining Satpathy lab, she worked as a Clinical Research Coordinator Assistant in UC Irvine Medical Center. 

Back to front

Getiara graduated from UC San Diego with her B.S. in Pharmacological Chemistry. As an undergrad, she worked as a tutor, and after graduating, she worked at a private clinic in downtown La Jolla. She also spent her time volunteering at her father’s research organization, IntelliScience Training Institute, as Coordinating Liaison. Now, she serves as an Administrative Assistant to Dr. Satpathy and Dr. Karin Pelka and is excited to contribute to both teams!

Back to front

Marie is a visiting research scholar in cancer immunogenomics from the Samuels Lab at the Weizmann Institute of Science. She earned her master’s degree in Life Science engineering at HTW Berlin and completed her thesis at ZHAW Zurich. Following graduate school, Marie joined Prof. Mitch Levesque’s research group at the University of Zurich, focusing on targeting TRK receptors in melanoma and validating amyloid analogues for the treatment of metastatic melanoma.

At the Satpathy Lab, Marie is leveraging a large-scale CRISPR/Cas9 screen to investigate the effect of cancer-specific dysregulated translation fidelity on immune interactions, aiming to identify novel immunotherapy targets.

Back to front

Wenxi is a Life Science Research Professional 1 in the Satpathy Lab. During her undergraduate studies, she worked in Dr. Matteo Pellegrini’s Lab on developing Epigenetic Pacemaker Model. She has also worked for Dr. Cizhong Jiang on the impact of histone chaperon FACT on chromatin remodeling in neuroblastoma.

Back to front

Royce is an Internal Medicine Resident in the Molecular Medicine Program at UCSF, where he is fast-tracked into Gastroenterology Fellowship. He completed his MD PhD at the Icahn School of Medicine at Mount Sinai where he studied microenvironment controlled super-enhancers in colorectal carcinoma. He is broadly interested in the epigenomics and transcriptional regulation of complex cancer and immune phenotypes, cancer metabolism, and gastrointestinal epithelial cancers. Previously, he graduated from Columbia University where he worked on the epigenetics of cocaine addiction with Nobel Laureate Dr. Eric Kandel.

Back to front